PATENT CLAIM ANALYSIS

Application Number: 16298762
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "293000"]

Abstract:
A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins.

Claim (Index 14):
The compound of  claim 1 , wherein, R 5  is selected from optionally substituted monocyclic rings having 1-3 heteroatoms independently selected from N, O and S and the optional substituents are selected from 1 to 2 halo, C 1-4 alkyl and C 1-4 alkoxy.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 99.0
- Lexical Diversity: 1.10714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15546324', '15619671', '15749950', '14204076', '15150492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8135705555094744
- 35 USC 102 Novelty (BERT): 0.5473415352813793
- Combined Prediction Score: 0.786947653486665
- Mean Citation Score: 341.494826
- Max Citation Score: 400.17456
- Similarity Product: 353.6337391888046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test